Using hyperbaric oxygen therapy to improve insulin resistance in postmenopausal women
Official title: Effect of Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopausal Women
Run by Cairo University · NCT06806345 · Data updated 2026-11-12
This study is testing if hyperbaric oxygen therapy can help improve insulin resistance in postmenopausal women who are struggling with high blood sugar levels.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 55 Years to 65 Years |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo, Cairo Governorate) |
| Status | Recruiting |
| Started | January 28, 2025 |
| Main results expected | March 28, 2025 |
| Study ends | April 28, 2025 |
| Registry record updated | February 4, 2025 |
| Trial ID | NCT06806345 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are postmenopausal women aged 55-65 with insulin resistance and a BMI between 30-34.9 kg/m² who are already managing their blood glucose levels with oral hypoglycemic drugs.
✕Probably not a fit
Patients with chronic obstructive pulmonary disease, cardiac pacemakers, epilepsy, physical disabilities, or other ulcer-causing disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of hyperbaric oxygen therapy on insulin resistance in postmenopausal women aged 55-65 with a BMI of 30-34.9 kg/m². Participants will receive hyperbaric oxygen therapy alongside hypoglycemic drugs to assess improvements in blood glucose levels and overall function. The study aims to identify clinical predictors that could enhance treatment efficiency and prevent complications associated with insulin resistance. By focusing on this demographic, the research seeks to address a significant public health issue in Egypt related to diabetes and cardiovascular diseases.
Why it matters
Potential benefit: If successful, this therapy could provide a novel treatment option for managing insulin resistance and improving the quality of life for postmenopausal women.
How similar studies have gone: While hyperbaric oxygen therapy has shown promise in various conditions, this specific application for insulin resistance in postmenopausal women is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A)Inclusion Criteria * All females were clinically diagnosed with Postmenopausal Insulin resistance. * Their ages were ranged from 55-65 years old. * Their BMI was 30-34.9 kg/m². * All patients should had controlled blood glucose levels by oral hypoglycemic drugs. * All patients should had cardiac Ejection Fraction \>or =50%. * Their Chest X-ray reported normal. * Their Ear ,nose , thorax will be clinically evaluated by a specialized ENT physician to ensure fitting for hyperbaric chamber * Voluntary acceptance of participation in the study . B)Exclusion Criteria: Participants will be excluded if they have : * Chronic obstructive pulmonary disease. * Cardiac pacemakers. * Epileptic fits. * Physically disable . * Any disorder that lead to ulcers other than diabetes such as ahistory of chronic peripheral arterial disease. Exclusion Criteria: \-
Where it's running
-
Kobry el koba military complex
Cairo, Cairo Governorate, Egypt Recruiting
Study contacts
- Study coordinator: Siham mohamed fahmy Head of Hyperbaric oxygen therapy unit, Assistant professor
- Email: Fahmysiham@gmail.com
- Phone: 01033380185
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Artichoke by-product supplement with an energy-restricted Mediterranean diet to prevent type 2 diabetes
This trial tests whether taking daily artichoke-derived capsules together with an energy-restricted Mediterranean diet can help adults with overweight or obesity and insulin resistance improve blood sugar control and lose weight.
-
Personalized daily step targets to change body fat and cardiometabolic risk in adults with overweight or obesity
This project will test if giving personalized daily step targets based on body fat helps adults with overweight or obesity change body composition and lower cardiometabolic risk.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
Palatal Shield Technique to Reduce Pain and Improve Healing After Free Gingival Graft
This randomized trial tests whether a collagen sponge with a protective palatal shield made of flowable resin helps reduce pain and improve healing after free gingival graft harvest.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
Video Microscope vs Loupe-Assist in Varicocelectomy
This study tests whether using a video telescopic operating microscope (VITOM) provides better outcomes and surgeon satisfaction than loupe-assisted varicocelectomy in adult men with grade II/III varicoceles.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.